Authors:
PHILLIPS PA
RISVANIS J
HUTCHINS AM
BURRELL LM
MACGREGOR D
GUNDLACH AL
JOHNSTON CI
Citation: Pa. Phillips et al., DOWN-REGULATION OF VASOPRESSIN V1A RECEPTOR MESSENGER-RNA IN DIABETES-MELLITUS IN THE RAT, Clinical science, 88(6), 1995, pp. 671-674
Citation: Pa. Phillips et B. Pawluczuk, FLOOR OVERLAY FOR REDUCING LEG ABRASION INJURIES ON PIGLETS, Canadian agricultural engineering, 37(3), 1995, pp. 231-233
Authors:
PHILLIPS PA
ROLLS KA
BURRELL LM
CASLEY D
ALDRED KL
HARDY KJ
Citation: Pa. Phillips et al., VASCULAR ENDOTHELIN RESPONSIVENESS AND RECEPTOR CHARACTERISTICS IN-VITRO AND EFFECTS OF ENDOTHELIN RECEPTOR BLOCKADE IN-VIVO IN CYCLOSPORINE HYPERTENSION, Clinical and experimental pharmacology and physiology, 21(3), 1994, pp. 223-226
Citation: Ka. Rolls et al., VASOCONSTRICTOR RESPONSES TO COMPONENTS OF THE RENIN-ANGIOTENSIN SYSTEM IN CYCLOSPORINE-INDUCED HYPERTENSION IN THE RAT, Clinical and experimental pharmacology and physiology, 21(3), 1994, pp. 227-230
Citation: Sl. Grant et al., INTERACTION BETWEEN EPIDERMAL GROWTH-FACTOR AND ARGININE-VASOPRESSIN IN RENAL MEDULLARY MEMBRANES, Clinical and experimental pharmacology and physiology, 21(3), 1994, pp. 243-247
Authors:
LIU JJ
PHILLIPS PA
BURRELL LM
BURTON BB
JOHNSTON CI
Citation: Jj. Liu et al., HUMAN INTERNAL MAMMARY ARTERY RESPONSES TO NONPEPTIDE VASOPRESSIN ANTAGONISTS, Clinical and experimental pharmacology and physiology, 21(2), 1994, pp. 121-124
Authors:
PHILLIPS PA
BURRELL LM
RISVANIS J
STEPHENSON J
JOHNSTON CI
HUTCHINS AM
Citation: Pa. Phillips et al., EFFECTS OF ANTIEMETICS ON WATER-EXCRETION IN HUMANS, Clinical and experimental pharmacology and physiology, 21(1), 1994, pp. 59-62
Authors:
HIERHOLZER JC
TANNOCK GA
HIERHOLZER CM
COOMBS RA
KENNETT ML
PHILLIPS PA
GUST ID
Citation: Jc. Hierholzer et al., SUBGROUPING OF RESPIRATORY SYNCYTIAL VIRUS-STRAINS FROM AUSTRALIA ANDPAPUA-NEW-GUINEA BY BIOLOGICAL AND ANTIGENIC CHARACTERISTICS, Archives of virology, 136(1-2), 1994, pp. 133-147
Authors:
BURRELL LM
PHILLIPS PA
STEPHENSON JM
RISVANIS J
ROLLS KA
JOHNSTON CI
Citation: Lm. Burrell et al., BLOOD-PRESSURE-LOWERING EFFECT OF AN ORALLY-ACTIVE VASOPRESSIN V(1) RECEPTOR ANTAGONIST IN MINERALOCORTICOID HYPERTENSION IN THE RAT, Hypertension, 23(6), 1994, pp. 737-743
Citation: Sl. Grant et al., INTERACTION BETWEEN EPIDERMAL GROWTH-FACTOR (EGF) AND ARGININE-VASOPRESSIN (AVP), Kidney international, 45(4), 1994, pp. 1262-1262
Authors:
PHILLIPS PA
TRINDER D
STEPHENSON J
RISVANIS J
COOPER M
JOHNSON CI
Citation: Pa. Phillips et al., DIFFERENTIAL REGULATION OF V1 AND V2 VASOPRESSIN RECEPTORS IN DIABETES-MELLITUS, Kidney international, 45(4), 1994, pp. 1275-1276
Authors:
PHILLIPS PA
HUTCHINS AM
BURRELL LM
RISVANIS J
JOHNSTON CI
Citation: Pa. Phillips et al., V-1-LIKE [ARG(8)]VASOPRESSIN BINDING-SITES OCCUR IN RAT HEPATOCYTE NUCLEI, European journal of pharmacology, 259(3), 1994, pp. 325-329
Authors:
MCNALLY PG
PHILLIPS PA
JOHNSTON CI
KOLTERMAN OG
COOPER ME
Citation: Pg. Mcnally et al., HUMAN AMYLIN INCREASES PLASMA-RENIN IN MAN - A POSSIBLE LINK BETWEEN HYPERTENSION AND INSULIN-RESISTANCE, Diabetologia, 37, 1994, pp. 10000046-10000046